Biotech Startup Verge Genomics Collects $98 Million

By Brian Gormley

Biotechnology company Verge Genomics has raised $98 million in new venture capital to use artificial intelligence and human genetics to uncover treatments for neurological diseases.

The complexity of diseases such as Parkinson’s and amyotrophic lateral sclerosis has thwarted many attempts to develop better treatments for neurological illnesses....